TrialBMC cancer2025

Effects of Bojungikki-Tang on immune response and clinical outcomes in NSCLC patients receiving immune checkpoint inhibitors: a randomized pilot study.

Mi Mi Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.